A Trial of SHR7280 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 19, 2025

Primary Completion Date

July 5, 2025

Study Completion Date

July 5, 2025

Conditions

EndometriosisUterine FibroidsAssisted Reproduction

Interventions

DRUG

SHR7280 Tablet

Oral SHR7280 tablet.

DRUG

SHR7280 Placebo Tablet

Oral SHR7280 placebo tablet.

Trial Locations (1)

Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY